Hypercalcemia of malignancy revisited.
Open Access
- 1 July 1988
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 82 (1) , 1-6
- https://doi.org/10.1172/jci113555
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987
- N-Terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: Identification of parathyroid hormone-like and parathyroid hormone-unlike domainsBiochemical and Biophysical Research Communications, 1987
- Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.Journal of Clinical Investigation, 1986
- Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.Journal of Clinical Investigation, 1985
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983
- Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.Journal of Clinical Investigation, 1983
- Absence of Parathyroid Hormone Messenger RNA in Nonparathyroid Tumors Associated with HypercalcemiaNew England Journal of Medicine, 1983
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980
- Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandinsNature, 1976
- RELATION BETWEEN SERUM AND URINARY CALCIUM WITH PARTICULAR REFERENCE TO PARATHYROID ACTIVITYThe Lancet, 1969